RODRIGUEZ-VICENTE, A.E., Vasileios BIKOS, V. HERNANDEZ-SANCHEZ, Jitka MALČÍKOVÁ, J.M. HERNANDEZ-RIVAS and Šárka POSPÍŠILOVÁ. Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons. Oncotarget. Albany: Impact Journals, 2017, vol. 8, No 41, p. 71234-71248. ISSN 1949-2553. Available from: https://dx.doi.org/10.18632/oncotarget.19525.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons
Authors RODRIGUEZ-VICENTE, A.E. (724 Spain), Vasileios BIKOS (300 Greece, belonging to the institution), V. HERNANDEZ-SANCHEZ (724 Spain), Jitka MALČÍKOVÁ (203 Czech Republic, belonging to the institution), J.M. HERNANDEZ-RIVAS (724 Spain) and Šárka POSPÍŠILOVÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition Oncotarget, Albany, Impact Journals, 2017, 1949-2553.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 5.168 in 2016
RIV identification code RIV/00216224:14110/17:00095686
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.18632/oncotarget.19525
UT WoS 000411153300165
Keywords in English chronic lymphocytic leukemia; next-generation sequencing; clonal evolution; immunogenetics; CLL prognosis
Tags EL OK, podil
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 20/3/2018 10:03.
Abstract
The rapid progress in next-generation sequencing technologies has significantly contributed to our knowledge of the genetic events associated with the development, progression and treatment resistance of chronic lymphocytic leukemia patients. Together with the discovery of new driver mutations, next-generation sequencing has revealed an immense degree of both intra- and inter-tumor heterogeneity and enabled us to describe marked clonal evolution. Advances in immunogenetics may be implemented to detect minimal residual disease more sensitively and to track clonal B cell populations, their dynamics and molecular characteristics. The interpretation of these aspects is indispensable to thoroughly examine the genetic background of chronic lymphocytic leukemia. We review and discuss the recent results provided by the different next-generation sequencing techniques used in studying the chronic lymphocytic leukemia genome, as well as future perspectives in the methodologies and applications.
Links
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
NV15-30015A, research and development projectName: Analýza klonální heterogenity chronické lymfocytární leukemie pomoci sekvenování nové generace genu pro B-buněčný receptor. Národní studie.
NV15-31834A, research and development projectName: Vliv selekce genomických poškození na průběh chronické lymfocytární leukémie
NV16-29447A, research and development projectName: Vyhledávání mutací predisponujících k familiárním hematologickým a onkologickým onemocněním
7E13008, research and development projectName: Next Generation Sequencing Platform for Targeted Personalized Therapy of Leukemia (Acronym: NGS-PTL)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 16/7/2024 23:18